Indicators
For a full listing see Australian Institute of Health and Welfare data by indicators
-
AHPF Indicator: Incidence of end-stage kidney disease
The number of new cases per 100,000 people, of treated end-stage kidney disease plus number of individuals who died with: an underlying cause of death of ‘chronic kidney failure’, ‘hypertensive kidney failure’ or ‘unspecified kidney failure’; or an associated cause of death of ‘chronic renal failure, end-stage’, and did not receive dialysis or transplant treatment (untreated cases). Available data: National -
IHPF Indicator: Kidney disease
Kidney disease is a major health issue for Aboriginal and Torres Strait Islander (First Nations) people who experience disproportionately high levels of kidney disease across all geographic areas, but particularly in remote areas. -
Kidney function test type – type 2 diabetes and/or CVD (PI18)
This indicator is the proportion of First Nations regular clients aged 18 and over with type 2 diabetes and/or cardiovascular disease (CVD) who, within the previous 12 months, had both an estimated glomerular filtration rate (eGFR) AND an albumin/creatinine ratio (ACR) test result recorded, only an eGFR test result recorded, only an ACR test result recorded, or neither an eGFR nor an ACR test result recorded. -
Kidney function test result (risk category) – type 2 diabetes and/or CVD (PI19)
This indicator is the proportion of First Nations regular clients aged 18 and over with type 2 diabetes and/or cardiovascular disease (CVD) who had both an estimated glomerular filtration rate (eGFR) AND an albumin/creatinine ratio (ACR) test result recorded within the previous 12 months.